What laboratory studies should be ordered for a 17‑year‑old female with mild anemia (Hb 11.8 g/dL, Hct 35.2%, MCH 26.9 pg, RDW 14.3%) and normal AST?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Workup for a 17-Year-Old Female with Mild Microcytic Anemia

Immediate First-Line Testing

Order a complete iron panel (serum ferritin, transferrin saturation, serum iron, and total iron-binding capacity) together with C-reactive protein, and begin oral ferrous sulfate 60 mg daily while awaiting results. 1

The patient's laboratory values—hemoglobin 11.8 g/dL (below the WHO threshold of 12 g/dL for non-pregnant women), MCH 26.9 pg (reduced), MCHC 33.5 g/dL (low-normal), and RDW 14.3% (elevated)—strongly suggest iron-deficiency anemia. 1, 2 The combination of low MCH with elevated RDW is highly specific for iron deficiency, as MCH is the most sensitive early marker of iron-restricted erythropoiesis and falls before frank microcytosis develops. 1, 2

Specific Iron Studies to Order

  • Serum ferritin < 30 µg/L confirms depleted iron stores when inflammation is absent and is the single most powerful test for iron deficiency. 1, 2

  • Transferrin saturation < 15–16% supports iron deficiency and remains reliable even when ferritin may be falsely elevated by inflammation. 1, 2

  • C-reactive protein (CRP) must be measured concurrently because ferritin is an acute-phase reactant; inflammation can mask true iron deficiency by elevating ferritin into the normal range. 1, 2

  • Total iron-binding capacity (TIBC) > 45 µmol/L provides additional confirmation of iron deficiency. 1

Additional Helpful Tests

  • Reticulocyte count should be obtained to assess bone marrow response; a low or inappropriately normal reticulocyte count in the setting of anemia confirms inadequate marrow compensation, consistent with iron deficiency. 1, 3

Empiric Treatment While Awaiting Results

Prescribe oral ferrous sulfate 60 mg elemental iron once daily, taken on an empty stomach between meals to maximize absorption. 1 This dosage is specifically recommended for adolescent females with mild anemia by CDC guidelines. 1

Provide dietary counseling to include iron-rich foods such as red meat, poultry, fish, fortified cereals, beans, and lentils, along with vitamin C-rich foods (citrus, tomatoes) to enhance absorption. 1

Four-Week Therapeutic Response Assessment

Re-measure hemoglobin and hematocrit at 4 weeks; an increase of ≥1 g/dL (or hematocrit rise ≥3%) confirms iron-deficiency anemia even if baseline iron studies were equivocal. 1 This therapeutic response validates the diagnosis and justifies continuation of therapy for an additional three months (total four-month course) to fully replenish iron stores. 1

Evaluation if No Response After 4 Weeks

If hemoglobin does not rise despite documented adherence to iron supplementation, order hemoglobin electrophoresis to exclude thalassemia trait. 1 Thalassemia minor typically shows RDW ≤ 14% (versus > 14% in iron deficiency), normal or borderline iron studies, and an MCV disproportionately low relative to the degree of anemia. 1, 2, 4, 5

The patient's RDW of 14.3% (elevated) strongly favors iron deficiency over thalassemia trait, which usually presents with RDW ≤ 14% because red cells are more uniform. 1, 2, 4 However, approximately 50% of thalassemia cases can exhibit an elevated RDW, so hemoglobin electrophoresis remains necessary if iron therapy fails. 1, 5

Assessment for Underlying Cause

In premenopausal adolescent females, menstrual blood loss is the most common cause of iron deficiency, but a careful menstrual history is essential to determine whether losses are adequate to explain the deficiency. 1 Assess for heavy menstrual bleeding, which may necessitate gynecologic referral. 1

Evaluate dietary iron intake, particularly vegetarian or vegan eating patterns, as these diets increase the risk of iron deficiency in adolescents. 1, 2

If menstrual losses seem inadequate to explain the deficiency, consider gastrointestinal sources by taking a careful history of NSAID use, gastrointestinal symptoms, and dietary factors. 1

Consider celiac disease screening with tissue transglutaminase (tTG) antibody testing, as malabsorption is a significant cause of iron deficiency with a prevalence of approximately 5% in iron-deficiency anemia. 1

Critical Pitfalls to Avoid

  • Do not rely on ferritin alone without CRP; inflammation can falsely elevate ferritin and mask true iron deficiency. 1, 2

  • Do not assume a normal MCV excludes iron deficiency; MCH typically falls before MCV in early deficiency, and the patient's MCH of 26.9 pg is already reduced. 1, 2

  • Do not limit evaluation to a CBC; WHO criteria for anemia require full iron studies for proper diagnosis. 1

  • Do not use hemoglobin electrophoresis as a first-line test; it should be reserved for cases with normal or borderline iron parameters after a therapeutic trial. 1, 2

Normal AST Interpretation

The normal AST level (11 IU/L) effectively rules out liver disease as a contributing cause, since hepatic disorders typically raise AST 2–6-fold above the upper limit of normal. 1

References

Guideline

Diagnosis and Management of Iron Deficiency Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Microcytic Hypochromic Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Anemia Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.